The Business Research Company’s Vasomotor Menopausal Symptoms (VMS) Treatment Global Market Report 2024 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Vasomotor Menopausal Symptoms (VMS) Treatment Global Market Report 2023 evaluates vasomotor menopausal symptoms (vms) treatment market size, growth rate, drivers, trends, and major companies.
The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=13051&type=smp
The global vasomotor menopausal symptoms (vms) treatment market is expected to grow from $16.6 billion in 2023 to $17.86 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to hormone replacement therapy (hrt), menopause awareness, pharmaceutical developments, consumer demand. The vasomotor menopausal symptoms (vms) treatment market size is expected to see strong growth in the next few years. It will grow to $23.11 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%.
The increase in the menopause population is expected to propel the growth of the vasomotor menopausal symptoms treatment market going forward. Menopause is a natural biological process that marks the end of a woman’s reproductive years. It is a significant life stage that typically occurs in women between the ages of 45 and 55, with the average age being around 51. The rising number of menopausal women, which demands treatment for hot flashes and vaginal dryness globally, is one of the primary factors pushing the growth of vasomotor menopausal symptoms (VMS) treatment. For instance, in November 2022, according to the Cuyuna Regional Medical Center, a US-based organization, estimated that by 2025, 1.1 billion women will be menopausal due to women living longer. Moreover, the population of menopausal will be increased by 1.6% annually until 2060. Therefore, the increase in the menopause population is driving the growth of the vasomotor menopausal symptoms treatment market.
Get More Information On The Vasomotor Menopausal Symptoms (VMS) Treatment Market Report:
The vasomotor menopausal symptoms (vms) treatment market segments in the report are:
1) By Drug Class: Antidepressants, Fluoxetine, Paroxetine, Sertraline, Hormone Therapy, Anticonvulsant, Phenytoin, Phenobarbital, Other Drug Classes
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
3) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users
The table of contents in TBRC’s vasomotor menopausal symptoms (vms) treatment market report includes:
Executive Summary
Vasomotor Menopausal Symptoms (VMS) Treatment Market Characteristics
Vasomotor Menopausal Symptoms (VMS) Treatment Market Trends And Strategies
Vasomotor Menopausal Symptoms (VMS) Treatment Market – Macro Economic Scenario
Global Vasomotor Menopausal Symptoms (VMS) Treatment Market Size and Growth
.
.
.
Vasomotor Menopausal Symptoms (VMS) Treatment Market Other Major And Innovative Companies
Global Vasomotor Menopausal Symptoms (VMS) Treatment Market Competitive Benchmarking
Global Vasomotor Menopausal Symptoms (VMS) Treatment Market Competitive Dashboard
Key Mergers And Acquisitions In The Vasomotor Menopausal Symptoms (VMS) Treatment Market
Vasomotor Menopausal Symptoms (VMS) Treatment Market Future Outlook and Potential Analysis
Top Major Players
Pfizer Inc.
Abbvie Inc.
Novartis AG
Ausio Pharmaceuticals LLC
Teva Pharmaceutical Industries Ltd.
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
